Structural and Mechanistic Insights into Atypical Bacterial Topoisomerase Inhibitors

被引:0
作者
Toth, Paul D. [1 ]
Ratigan, Steven C. [2 ]
Powell, Joshua W. [2 ]
Cassel, Sydney R. [3 ]
Yalowich, Jack C. [3 ]
McElroy, Craig A. [2 ]
Lindert, Steffen [1 ]
Bell, Charles E. [4 ]
Mitton-Fry, Mark J. [2 ]
机构
[1] Ohio State Univ, Coll Arts & Sci, Dept Chem & Biochem, Columbus, OH 43210 USA
[2] Ohio State Univ, Coll Pharm, Div Med Chem & Pharmacognosy, Columbus, OH 43210 USA
[3] Ohio State Univ, Coll Pharm, Div Pharmaceut & Pharmacol, Columbus, OH 43210 USA
[4] Ohio State Univ, Coll Med, Dept Biol Chem & Pharmacol, Columbus, OH 43210 USA
来源
ACS MEDICINAL CHEMISTRY LETTERS | 2025年
基金
美国国家卫生研究院;
关键词
gyrase; amide; triazole; crystallography; moleculardynamics; DNA GYRASE; DERIVATIVES; SAR;
D O I
10.1021/acsmedchemlett.5c00060
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Novel bacterial topoisomerase inhibitors (NBTIs) targeting DNA gyrase and topoisomerase IV constitute a new antibacterial class for deadly pathogens such as MRSA. While most NBTIs induce gyrase-mediated single-strand DNA breaks, a subset of amide NBTIs induces both single-strand and double-strand DNA breaks. Here, we report the X-ray crystal structures of two such amide NBTIs, 148 and 185, and demonstrate an unusual binding mode characterized by engagement of both GyrA D83 and R122. The synthesis of two isosteric triazole NBTIs is also described, one of which (342) affords only single-strand DNA breaks, while the other (276) also induces both single- and double-strand DNA breaks. A combination of docking and molecular dynamics simulations is employed to further investigate the potential structural underpinnings of differences in DNA cleavage.
引用
收藏
页码:660 / 667
页数:8
相关论文
共 50 条
  • [41] Synthesis and anti-staphylococcal activity of novel bacterial topoisomerase inhibitors with a 5-amino-1,3-dioxane linker moiety
    Li, Linsen
    Okumu, Antony
    Dellos-Nolan, Sheri
    Li, Zoe
    Karmahapatra, Soumendrakrishna
    English, Anthony
    Yalowich, Jack C.
    Wozniak, Daniel J.
    Mitton-Fry, Mark J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (14) : 2477 - 2480
  • [42] Novel 3-fluoro-6-methoxyquinoline derivatives as inhibitors of bacterial DNA gyrase and topoisomerase IV
    Mitton-Fry, Mark J.
    Brickner, Steven J.
    Hamel, Judith C.
    Barham, Rose
    Brennan, Lori
    Casavant, Jeffrey M.
    Ding, Xiaoyuan
    Finegan, Steven
    Hardink, Joel
    Thuy Hoang
    Huband, Michael D.
    Maloney, Meghan
    Marfat, Anthony
    McCurdy, Sandra P.
    McLeod, Dale
    Subramanyam, Chakrapani
    Plotkin, Michael
    Reilly, Usa
    Schafer, John
    Stone, Gregory G.
    Uccello, Daniel P.
    Wisialowski, Todd
    Yoon, Kwansik
    Zaniewski, Richard
    Zook, Christopher
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (15) : 3353 - 3358
  • [43] Rational design, synthesis and testing of novel tricyclic topoisomerase inhibitors for the treatment of bacterial infections part 2
    Kirk, R.
    Ratcliffe, A.
    Noonan, G.
    Uosis-Martin, M.
    Lyth, D.
    Bardell-Cox, O.
    Massam, J.
    Schofield, P.
    Lyons, A.
    Clare, D.
    Maclean, J.
    Smith, A.
    Savage, V.
    Mohmed, S.
    Charrier, C.
    Salisbury, A-M.
    Moyo, E.
    Ooi, N.
    Chalam-Judge, N.
    Cheung, J.
    Stokes, N. R.
    Best, S.
    Craighead, M.
    Armer, R.
    Huxley, A.
    RSC MEDICINAL CHEMISTRY, 2020, 11 (12): : 1379 - 1385
  • [44] Structural and biological studies on bacterial nitric oxide synthase inhibitors
    Holden, Jeffrey K.
    Li, Huiying
    Jing, Qing
    Kang, Soosung
    Richo, Jerry
    Silverman, Richard B.
    Poulos, Thomas L.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (45) : 18127 - 18131
  • [45] Topoisomerase II inhibitors design: Early studies and new perspectives
    Swedan, Hadeer K.
    Kassab, Asmaa E.
    Gedawy, Ehab M.
    Elmeligie, Salwa E.
    BIOORGANIC CHEMISTRY, 2023, 136
  • [46] Insights into podophyllotoxin lactone features: New cyclolignans as potential dual tubulin-topoisomerase II inhibitors
    Hernandez, Angela-Patricia
    Rosales-Fernandez, Celia
    Miranda-Vera, Carolina
    Veselinova, Anzhela
    Jambrina, Pablo G.
    Garcia-Garcia, Pilar
    Garcia, Pablo A.
    Diez, David
    Castro, Maria Angeles
    Fuentes, Manuel
    ARCHIV DER PHARMAZIE, 2025, 358 (01)
  • [47] Discovery and structure-activity relationships of a novel isothiazolone class of bacterial type II topoisomerase inhibitors
    Cooper, Ian R.
    McCarroll, Andrew J.
    McGarry, David
    Kirkham, James
    Pichowicz, Mark
    Walker, Rolf
    Warrilow, Catherine
    Salisbury, Anne-Marie
    Savage, Victoria J.
    Moyo, Emmanuel
    Forward, Henry
    Cheung, Jonathan
    Metzger, Richard
    Gault, Zoe
    Nelson, Gary
    Hughes, Diarmaid
    Cao, Sha
    Maclean, John
    Charrier, Cedric
    Craighead, Mark
    Best, Stuart
    Stokes, Neil R.
    Ratcliffe, Andrew J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (17) : 4179 - 4183
  • [48] Structural and mechanistic insights into the oxy form of tyrosinase from molecular dynamics simulations
    Robert J. Deeth
    Christian Diedrich
    JBIC Journal of Biological Inorganic Chemistry, 2010, 15 : 117 - 129
  • [49] Impact of Mutations on NPAC Structural Dynamics: Mechanistic Insights from MD Simulations
    Montefiori, Marco
    Pilotto, Simona
    Marabelli, Chiara
    Moroni, Elisabetta
    Ferraro, Mariarosaria
    Serapian, Stefano A.
    Mattevi, Andrea
    Colombo, Giorgio
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2019, 59 (09) : 3927 - 3937
  • [50] Structural and mechanistic insights into the oxy form of tyrosinase from molecular dynamics simulations
    Deeth, Robert J.
    Diedrich, Christian
    JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY, 2010, 15 (02): : 117 - 129